Standout Papers

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis pat... 2015 2026 2018 2022 260
  1. Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients (2015)
    Lisa Rice, Cristina M. Padilla et al. Journal of Clinical Investigation

Citation Impact

2 by Nobel laureates 8 from Science/Nature 65 standout
Sub-graph 1 of 21

Citing Papers

Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021 Standout
Fibroblasts: Origins, definitions, and functions in health and disease
2021 Standout
2 intermediate papers

Works of Michael York being referenced

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
2015 Standout
Poly(I:C) Drives Type I IFN- and TGFβ-Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic Sclerosis
2010

Author Peers

Author Small Animals PFM Rheumatology Immunology Dermatology Last Decade Papers Cites
Michael York 384 792 267 612 439 40 2.5k
Bernadette Baker 2 50 618
M.S. Brancato 2 7 300
A. Clark 2 3 2 31 1.1k
Yeong-Han Chun 20 279
Frances M. Nilsen 4 1 3 5 12 316

All Works

Loading papers...

Rankless by CCL
2026